Sciences de la vie

Bienvenue sur lapage d'accueil sciences de la vie de Law-Now.

Sur cette page, vous pouvez accéder à des articles et des publications relatifs au secteur de sciences de la vie, rédigés par les experts de CMS.

Pour rester informés des dernières évolutions, veuillez ajouter cette page à vos favoris sur votre mobile ou vous inscrire pour recevoir les eAlerts.

eAlerts Récentes

  •  
    13/06/2024
    Europe

    What’s in a name? The use of a product code in a clinical trial protocol fails to circumvent clinical trial prior art

    The use of product or sponsor codes in clinical trial related documents is common practice in the pharmaceutical space. However, such codes may not always be sufficient to disregard a publication as relevant prior art against patent claims.In recent decision T 1255/21, the EPO Board of Appeal finds that the use of a product code or sponsor code for a compound or composition in a clinical trial protocol does not affect the status of the protocol as prior art if the skilled person would have been able to identify the compound or composition based on the description of the components of the product...
    Lire la suite
  •  
    13/06/2024
    United Kingdom

    UK Government publishes key updates to NSI Act guidance

    Overview of the key updates  On 21 May 2024 the UK Government published updated guidance on the scope and application of the UK National Security and Investment Act (NSIA).  The changes respond to some of the stakeholder feedback received during the Government’s November 2023 Call for Evidence on how to hone the scope of the NSIA.  They also aim to fulfil the Government’s commitment in April 2024 to provide further clarity on the NSIA to institutions, businesses and advisers grappling with its application in practice.  Key updates include:Guidance on higher education:...
    Lire la suite
  •  
    27/05/2024
    Europe

    Vital Signs Spring 2024

    As we push on into 2024 and towards summer, both the weather and some legal areas are hotting up. This edition of Vital Signs looks in detail at recent developments in four diverse legal areas. First, we review the current risks and trends in commercial contracts in the life science sector. Second, we consider how the law on supplementary protection certificates (SPCs) is developing, including the status of the EU pharma law package, CJEU referrals and national case law at the supreme court level. Third, brace yourself for an important decision in UK law on public procurement and the test for the...
    Lire la suite
  •  
    22/05/2024
    Italy

    Digital nomad tax insights

    The new visa for digital nomads might become a particularly interesting option for workers who may benefit from the so called “impatriate” tax regime following their relocation to Italy. The Decree of February 29, 2024, in force since April 5th, has established the entry and residence permit issuance procedures for "digital nomads" and "remote workers".The provisions apply to non-EU citizens who perform highly skilled work using technological tools that allow remote work; more specifically this definition refers to self-employed foreign workers (digital nomads) or foreign employees...
    Lire la suite
  •  
    16/05/2024
    Europe

    A broader interpretation of "substance or composition" - good news for patentees at the EPO?

    A recent decision from the EPO Boards of Appeal (T 1252/20) potentially paves the way for more diverse products to be patentable in Europe using the medical use claim format.The background:Article 53(c) of the European Patent Convention (EPC) excludes methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body from patentability. However, this does not apply to products, in particular substances or compositions, for use in any of these methods.Furthermore, Articles 54(4) and (5) EPC provide that a claim to a known substance...
    Lire la suite
  •  
    14/05/2024
    Hongrie

    EU introduces criminal offences and penalties for sanctions violations

    Criminal offencesUnder the Directive, the following conduct constitutes a criminal offence when committed intentionally and in violation of restrictive measures or a national provision implementing restrictive measures:making funds or economic resources available directly or indirectly to, or for the benefit of, a designated person, entity or body;failing to freeze funds or economic resources belonging to or owned, held or controlled by a designated person, entity or body;enabling designated natural persons to enter into, or transit through, the territory of a EU member state;entering into or continuing...
    Lire la suite